BOSTON, June 4, 2014 /PRNewswire/ -- PAREXEL
International Corporation (NASDAQ: PRXL) announced today that it
will be presenting at the Goldman Sachs Healthcare Conference in
Palos Verdes, CA. James
Winschel, Executive Vice President, will be making a
presentation on PAREXEL and discussing business developments at
3:20 p.m. PDT on Tuesday, June 10,
2014.
A live webcast of the discussion will be available through the
"Investors" section of PAREXEL's website at www.PAREXEL.com
in the Upcoming Events portion of the main page, and a replay of
the presentation will be available on the website until
September 10, 2014.
About PAREXEL International
PAREXEL International
Corporation is a leading global biopharmaceutical services
organization, providing a broad range of knowledge-based contract
research, consulting, medical communications, and technology
solutions and services to the worldwide pharmaceutical,
biotechnology and medical device industries. Committed to providing
solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development
and commercialization continuum, from drug development and
regulatory consulting to clinical pharmacology, clinical trials
management, medical education and reimbursement. PAREXEL
Informatics, Inc., a subsidiary of PAREXEL, provides advanced
technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 75
locations in 50 countries around the world, and has approximately
15,335 employees. For more information about PAREXEL
International visit www.PAREXEL.com.
PAREXEL, PAREXEL Informatics, Perceptive, Perceptive MyTrials,
and "Your Journey. Our Mission." are trademarks or registered
trademarks of PAREXEL International Corporation or its
affiliates.
Contact:
Jill Baker, Corporate Vice
President, Investor Relations
PAREXEL International
Tel: +781-434-4118
Email: Jill.Baker@parexel.com
SOURCE PAREXEL International Corporation